Dr. Patel is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
676 N. St. Clair
Suite 850
Chicago, IL 60610Phone+1 312-695-6180Fax+1 312-695-0990
Education & Training
Memorial Sloan Kettering Cancer CenterFellowship, Hematology and Medical Oncology, 2000 - 2003
McGaw Medical Center of Northwestern UniversityResidency, Internal Medicine, 1996 - 2000
Indiana University School of MedicineClass of 1996
Certifications & Licensure
IL State Medical License 1996 - 2026- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- Fellow of the American Society of Clinical Oncology American Society of Clinical Oncology, 2018
- Meaningful Use Stage 1 Certification Centers for Medicare & Medicaid Services, 2011
- Super Doctor SuperDoctors.com
- Join now to see all
Clinical Trials
- Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Start of enrollment: 2008 Jan 01
- A Study of AT13387 in Patients With Non-Small Cell Lung Cancer (NSCLC) Alone and in Combination With Crizotinib Start of enrollment: 2012 Oct 01
- Immunotherapy Study in Progressive or Relapsed Non-Small Cell Lung Cancer Start of enrollment: 2013 Feb 01
- Join now to see all
Publications & Presentations
PubMed
- 43 citationsClinical cancer advances 2012Bruce J. Roth, Lada Krilov, Sylvia Adams, Carol Aghajanian, Peter B. Bach
Journal of Clinical Oncology. 2013-01-01 - 297 citationsPhase II Trial of Atezolizumab As First-Line or Subsequent Therapy for Patients With Programmed Death-Ligand 1-Selected Advanced Non-Small-Cell Lung Cancer (BIRCH).Solange Peters, Scott N. Gettinger, Melissa Lynne Johnson, Pasi A. Jänne, Marina Chiara Garassino
Journal of Clinical Oncology. 2017-06-13 - 26 citationsAssessment of Tumor Mutational Burden and Outcomes in Patients With Diverse Advanced Cancers Treated With Immunotherapy.Charu Aggarwal, Rotem Ben-Shachar, Yinjie Gao, Seung Won Hyun, Zachary Rivers
JAMA Network Open. 2023-05-01
Press Mentions
Immunotherapy May Soon Be First-Line Tx for Advanced NSCLCJuly 2nd, 2016
E-cigarette Users Often Believe Devices Will Help Them Quit Tobacco - US NewsJune 4th, 2015
Cancer Study Could Change Radiation Treatment for Hundreds of ThousandsMay 31st, 2015- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
